Welgene Biotech Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	224.33	173.5	188.13	158.59	199.77
Short-Term Investments	43	53	9	59	21
Trading Asset Securities	-	-	-	-	2.72
Cash & Short-Term Investments	267.33	226.5	197.13	217.59	223.49
Cash Growth	18.03%	14.90%	-9.40%	-2.64%	23.24%
Accounts Receivable	46.7	45.58	46.98	46.57	82.86
Other Receivables	1.4	3.61	3.24	0.75	4.28
Receivables	48.09	49.19	50.23	47.31	87.14
Inventory	39.08	36.88	53.77	33.98	26.99
Prepaid Expenses	4.63	5.96	4.45	2.46	2.74
Other Current Assets	4.69	1.7	0.71	0.86	0.77
Total Current Assets	363.83	320.22	306.28	302.2	341.13
Property, Plant & Equipment	234.45	174.88	198.82	78.63	30.67
Long-Term Investments	17.61	26.12	33.98	42.09	41.36
Other Intangible Assets	0.65	0.16	0.39	0.73	1.07
Long-Term Deferred Tax Assets	0.51	0.44	0.56	0.49	0.69
Other Long-Term Assets	5.15	6.42	8.13	11.57	9.62
Total Assets	622.19	528.25	548.16	435.71	424.54
Accounts Payable	25.17	16.91	17.37	18.99	12.53
Accrued Expenses	-	24.28	21.18	25.02	26.61
Short-Term Debt	12	9	11	11.21	12.56
Current Portion of Long-Term Debt	28.54	11.68	11.05	-	-
Current Portion of Leases	14.55	13.58	13.33	13.08	11.28
Current Income Taxes Payable	-	0.36	-	2.44	-
Current Unearned Revenue	54.2	56.13	46.18	29.45	46.53
Other Current Liabilities	29.95	4.66	7.84	4.51	4.71
Total Current Liabilities	164.4	136.59	127.94	104.71	114.22
Long-Term Debt	141.19	95.58	105.4	-	-
Long-Term Leases	30.25	-	13.58	26.9	-
Pension & Post-Retirement Benefits	-	-	-	0.12	0.24
Long-Term Deferred Tax Liabilities	0.26	0.32	0.3	0.03	0.02
Other Long-Term Liabilities	0.02	0.02	0.68	-	-
Total Liabilities	336.12	232.5	247.89	131.76	114.47
Common Stock	233.04	233.04	233.04	233.04	233.04
Additional Paid-In Capital	50.93	50.86	50.86	50.86	50.86
Retained Earnings	21.29	20.62	19.51	27.18	28.88
Comprehensive Income & Other	-23.97	-16.61	-11.38	-7.32	-2.92
Total Common Equity	281.3	287.91	292.03	303.76	309.86
Minority Interest	4.78	7.84	8.24	0.2	0.21
Shareholders' Equity	286.07	295.75	300.27	303.95	310.06
Total Liabilities & Equity	622.19	528.25	548.16	435.71	424.54
Total Debt	226.53	129.83	154.35	51.19	23.84
Net Cash (Debt)	40.8	96.66	42.78	166.4	199.64
Net Cash Growth	-57.79%	125.94%	-74.29%	-16.65%	31.38%
Net Cash Per Share	1.84	4.15	1.84	7.13	8.64
Filing Date Shares Outstanding	18.75	23.3	23.3	23.3	23.3
Total Common Shares Outstanding	18.75	23.3	23.3	23.3	23.3
Working Capital	199.43	183.63	178.34	197.49	226.92
Book Value Per Share	15.00	12.35	12.53	13.03	13.30
Tangible Book Value	280.65	287.75	291.64	303.03	308.79
Tangible Book Value Per Share	14.96	12.35	12.51	13.00	13.25
Land	-	22.76	22.76	-	-
Buildings	-	97.7	97.7	-	-
Machinery	-	93.49	107.46	77.2	55.9

Source: S&P Global Market Intelligence. Standard template. Financial Sources.